SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India reports 39% rise in Q4 net profit

18 May 2022 Evaluate

Abbott India has reported results for fourth quarter and year ended March 31, 2022.

The company has reported a rise of 38.66% in its net profit at Rs 211.41 crore for the quarter under review as compared to Rs 152.47 crore for the same quarter in the previous year. Total income of the company increased by 14.47% at Rs 1,276.07 crore for Q4FY22 as compared Rs 1,114.74 crore for the corresponding quarter previous year.

For the year ended March 31, 2022, the company has reported a rise of 15.64% in its net profit at Rs 798.70 crore as compared to Rs 690.69 crore for the previous year. Total income of the company increased by 13.79% at Rs 4,996.48 crore for year under review as compared to Rs 4,390.92 crore for year ended March 31, 2021.

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×